Abiopharma

New Form 6-K - OKYO Pharma Ltd Filed: 2025-06-11 AccNo: 0001641172-25-014635 Size: 65 KB

Lisata Therapeutics to Present at the 2025 BIO International Convention

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

New Form 8-K - Harmony Biosciences Holdings, Inc. Filed: 2025-06-11 AccNo: 0001558370-25-008525 Size: 214 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Veru to Participate in the Virtual BTIG Obesity Health Forum

Artelo Biosciences Announces Reverse Stock Split

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

Intensity Therapeutics, Inc. Announces Patients Receiving INT230-6 Prior to the Start of Standard-of-Care May Achieve High Levels of Tumor Necrosis in the Ongoing Randomized Controlled Phase 2 INVINCIBLE-4 Study

Artelo Biosciences Announces Reverse Stock Split

OKYO Pharma to Present at the Bio International Convention

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing

New Form 6-K - Haleon plc Filed: 2025-06-11 AccNo: 0001654954-25-006816 Size: 34 KB

Hoth Therapeutics Notification (HOTH)

SeaStar Medical - AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStarMedical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research